What smart money is saying about Terns Pharmaceuticals, Inc.
TERN
No fund has written a full thesis on Terns Pharmaceuticals, Inc. in our archive, but 1 fund letter reports a position in it — most recently Baron Health Care Fund in June 2026.
1
Reported positions
0
Bought
1
Sold
1
Letter
Position history
Every position in Terns Pharmaceuticals, Inc. on record in the archive was reported in Q2 2026, across 1 fund letter — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
Fund activity · 1 position · 1 move
- ExitedBaron Health Care FundJune 2026
“We sold Apogee Therapeutics, Inc. and Terns Pharmaceuticals, Inc. following announcements that they were being acquired, Apogee by AbbVie Inc. and Terns by Merck & Co., Inc. , another Fund holding .”
Read the letterTerns Pharmaceuticals, Inc.
Read the letters behind these Terns Pharmaceuticals, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger